Growth Metrics

Gyre Therapeutics (GYRE) FCF Margin (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,886.00
Dec 31, 2025 -2,831.00
Sep 30, 2025 587.00
Jun 30, 2025 813.00
Mar 31, 2025 852.00
Dec 31, 2024 -1,371.00
Sep 30, 2024 3,160.00
Jun 30, 2024 -3,731.00
Mar 31, 2024 595.00
Dec 31, 2023 -1,369.00
Sep 30, 2023 1,049.00
Jun 30, 2023 -2,779.00
Mar 31, 2023 -688.00
Mar 31, 2022 -79,321.00
Dec 31, 2021 23,651.00
Sep 30, 2021 81,671.00
Jun 30, 2021 -11,739.00
Mar 31, 2021 -57,144.00
Dec 31, 2020 38,968.00
Sep 30, 2020 -56,463.00
Jun 30, 2020 -88,450.00
Mar 31, 2018 -8.64 Mn
Dec 31, 2017 -44,277.00
Sep 30, 2017 241,577.00
Jun 30, 2017 -238,089.00
Mar 31, 2017 559,682.00
Dec 31, 2016 -247,435.00
Sep 30, 2016 -115,046.00
Jun 30, 2016 87,706.00
Mar 31, 2016 37,339.00
Dec 31, 2015 402,661.00
Sep 30, 2015 -867,481.00
Jun 30, 2015 28,431.00
Mar 31, 2015 -13,705.00
Dec 31, 2014 -385,832.00
Sep 30, 2014 655,293.00
Jun 30, 2014 199,764.00
Mar 31, 2014 -3.00 Mn
Mar 31, 2013 173,377.00
Dec 31, 2012 -64,463.00
Sep 30, 2012 -130,289.00
Jun 30, 2012 5,735.00
Mar 31, 2012 55.00
Dec 31, 2011 -1,342.00
Sep 30, 2011 1,691.00
Jun 30, 2011 -5,511.00
Mar 31, 2011 2,095.00
Dec 31, 2010 1.26 Mn